Spotlight on mCRC
Welcome to the second edition of Spotlight on mCRC with: Real-world experiences in mCRC
THURSDAY, 25TH SEPTEMBER 2025 17:00-19:00 CEST – STREAMED ONLINE
Chaired by
JULIEN TAIEB
Head of the Gastroenterology and Gastrointestinal Oncology Department
Hôpital Européen Georges-Pompidou, Université de Paris, France
FACULTY
The Value of Real-World Evidence in mCRC
MIRIAM KOOPMAN
University Medical Center Utrecht Utrecht, Netherlands
MICHAEL NEUMAIER
Universitätsmedizin Mannheim Institut für Klinische Chemie Mannheim, Germany
ELENA ÉLEZ
Vall d’Hebron Institute of Oncology Barcelona, Spain
Clinical Cases in mCRC and Best Practices
MARTINA AMNITZBØLL ERIKSEN
Rigshospitalet Copenhagen, Denmark
SÉRGIO XAVIER AZEVEDO
Faculdade de Medicina da Universidade do Porto Porto, Portugal
IOANNIS SOUGLAKOS
University of Crete Crete, Greece
AGENDA
The Value of Real-World Evidence in mCRC
Welcome and Introduction Julien Taieb, Andrea Grignolio
How should real-world data from mCRC make a difference? Miriam Koopman
Real-world insights into the treatment of specific mCRC alterations Elena Élez
Using molecular biomarkers in the real world: Trends and challenges Michael Neumaier
Clinical Cases in mCRC and Best Practices
Opening and overview of the clinical cases Julien Taieb
A patient with BRAFV600E-mutant and MSI-H mCRC Martina Amnitzbøll Eriksen
A patient with KRASG12C-mutant mCRC Sérgio Xavier Azevedo
A patient with HER2 overexpression Ioannis Souglakos
Q&A Session & Closing
See detailed agenda HERE
LUNGCANCER SYMPOSIUM ON TARGETED THERAPY
Pierre Fabre invites to symposium / webinar September 30, 16.00-18.40
Prof. Niels Reinmuth, Dr Ronny Öhman, Dr Björn Båtshake
Stockholm, August 2025
Intended for Specialists with an interest in NSCLC
We are pleased to invite you to the meeting ”Lungcancer Symposium on Targeted Therapy” in Lund on September 30, 2025. During this meeting, experts will discuss the latest insights in the treatment of targeted therapy in NSCLC with focus on BRAF mutated NSCLC.
Special invited speaker: Professor Niels Reinmuth, Asklepios Lung Clinic Gauting, München, Germany, Senior consultants Ronny Öhman, and Björn Båtshake at Skåne University Hospital in Lund
Venue: Föreläsningssal 4, Blocket, Skånes universitetssjukhus Lund. The meeting will be streamed live as well. Register below.
Program
16:00 – 16:30 Coffee
16:30 – 16:40 Introduction, Senior Consultant Ronny Öhman, Skåne University hospital Lund
16:40 – 17:25 Challenges and future directions for treatment of NSCLC with oncogenic mutations, Prof. Niels Reinmuth, Asklepios Lung Clinic Gauting, München, Germany
17:25 – 17:45 Practical experience from Malignant Melanoma, Senior Consultant Björn Båtshake, Skåne University hospital Lund
17:45 – 18:00 Break
18:00 – 18:30 Patient cases and discussion, Senior Consultant Ronny Öhman, and Prof Niels Reinmuth
18:30 – 18:40 Closing remarcs, Senior Consultant Ronny Öhman
Prof Niels Reinmuth background
Dr. Niels Reinmuth is a certified specialist in ”General Medicine”, Hematology/Oncology, and Pneumology, with a postdoctoral qualification from the University of Heidelberg. He was Senior Physician at the Lung Clinic Grosshansdorf (2012–2016) and has led the Thoracic Oncology Department at Asklepios Lung Clinic Munich-Gauting since 2016. His main interests include targeted therapies for non-small-cell lung cancer, new treatments for small-cell lung cancer and malignant pleural mesothelioma, and translational research on predictive markers. He is a member of several professional societies, including IASLC, ESMO, and ASCO.
Registration can be made to Michael Rustner via email, [email protected].
Immunonkologi i klinisk praxis, IO-veckan 2025
BMS bjuder in till årets upplaga av immunonkologiveckan där vi bjuder på föreläsningar och fallbaserade sessioner som sätter fokus på kliniska situationer inom området och hoppas detta ska ge möjlighet till utbyte av värdefulla erfarenheter. Varmt välkommen!
Program:
Måndag 6 oktober kl 12.05 – 12.50
Progress och immunterapi: Från radiologiskt utlåtande till behandlingsbeslut
Föreläsare: Vitali Grozman
Moderator: Fernanda Costa Svedman
Tisdag 7 oktober kl 12.05 – 12.50
Immunotherapy for Elderly and Frail patients: Challenges and Opportunities in a new era of cancer treatment
Föreläsare: Per Pfeiffer, Denmark
Moderator: Jakob Eberhard
Onsdag 8 oktober kl 12.05 – 12.50
Immunrelaterade biverkningar – när kortison inte räcker
Föreläsare: Aikaterini Chatzidionysiou och Jan Marsal
Moderator: Ana Carneiro
Torsdag 9 oktober kl 12.05 – 12.50
Follow-up during and after treatment with immune checkpoint inhibitors – what can we learn from real life studies?
Föreläsare: Eva Ellebæk, Denmark
Moderator: Lars Ny
Fredag 10 oktober kl 12.05 – 12.50
Kliniska dilemman från veckan – Hur resonerar experterna?
Panel: Fernanda Costa Svedman, Jakob Eberhard, Ana Carneiro och Lars Ny
Moderator: BMS
Bristol Myers Squibb står för arvode till föreläsare vid sammankomsten. Anmälan kräver huvudmannens godkännande. Det åligger den enskilde deltagaren att inhämta detta.
